Ledger. Australian venture funding, tracked

Chief Innovation Officer, NEXSEN BioTech

Professor Vipul Bansal

Coverage

Stories naming Professor Vipul Bansal. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage $8m

Nexsen Limited (ASX:NXN) Successfully Lists on the ASX Following $8 Million Initial Public Offering

Australian nanobiotech firm Nexsen has begun trading on the sharemarket after an $8m IPO; earlier government grants and an RMIT research collaboration are also noted.

Also proactiveinvestors.com·Mirage News

Something wrong? Tell us